Shanghai Rendu Biotechnology Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 70.50%

Shanghai Rendu Biotechnology Co. Ltd. A (688193) has an Asset Resilience Ratio of 70.50% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shanghai Rendu Biotechnology Co. Ltd. A total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥693.75 Million

≈ $101.52 Million USD Cash + Short-term Investments

Total Assets

CN¥984.02 Million

≈ $143.99 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Shanghai Rendu Biotechnology Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688193 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Rendu Biotechnology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai Rendu Biotechnology Co. Ltd. A market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥693.75 Million	70.5%
Total Liquid Assets	CN¥693.75 Million	70.50%

Asset Resilience Insights

Very High Liquidity: Shanghai Rendu Biotechnology Co. Ltd. A maintains exceptional liquid asset reserves at 70.50% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Shanghai Rendu Biotechnology Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai Rendu Biotechnology Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Dr. Lal Path Labs Ltd. NSE:LALPATHLAB	Diagnostics & Research	13.43%
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Check-Cap Ltd. NASDAQ:MBAI	Diagnostics & Research	2.90%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%

Annual Asset Resilience Ratio for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai Rendu Biotechnology Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	70.04%	CN¥693.47 Million ≈ $101.48 Million	CN¥990.17 Million ≈ $144.89 Million	+18.65pp
2024-12-31	51.39%	CN¥510.96 Million ≈ $74.77 Million	CN¥994.36 Million ≈ $145.51 Million	+46.63pp
2023-12-31	4.76%	CN¥50.21 Million ≈ $7.35 Million	CN¥1.05 Billion ≈ $154.34 Million	-44.01pp
2022-12-31	48.77%	CN¥530.98 Million ≈ $77.70 Million	CN¥1.09 Billion ≈ $159.31 Million	+31.60pp
2019-12-31	17.17%	CN¥32.12 Million ≈ $4.70 Million	CN¥187.07 Million ≈ $27.37 Million	--

pp = percentage points

About Shanghai Rendu Biotechnology Co. Ltd. A

SHG:688193 China Diagnostics & Research

Market Cap

$310.65 Million

CN¥2.12 Billion CNY

Market Cap Rank

#14888 Global

#4536 in China

Share Price

CN¥52.98

Change (1 day)

-2.47%

52-Week Range

CN¥38.09 - CN¥61.67

All Time High

CN¥63.91